Gross profit · 2011–2025
Elite Pharmaceuticals gross profit
$75.0M+87.2% · FY2025
Elite Pharmaceuticals (ELTP) reported $75.0M in gross profit for fiscal 2025, +87.2% year on year.
| Fiscal year | Gross profit | Change | Filing |
|---|---|---|---|
| FY20252026-03-31 | $75.0M | +87.2% | Open → |
| FY20242025-03-31 | $40.1M | +52.1% | Open → |
| FY20232024-03-31 | $26.4M | +58.8% | Open → |
| FY20222023-03-31 | $16.6M | +12.2% | Open → |
| FY20212022-03-31 | $14.8M | +24.7% | Open → |
| FY20202021-03-31 | $11.9M | +48.7% | Open → |
| FY20192020-03-31 | $8.0M | +178.2% | Open → |
| FY20182019-03-31 | $2.9M | −27.4% | Open → |
| FY20172018-03-31 | $3.9M | +5.6% | Open → |
| FY20162017-03-31 | $3.7M | −53.3% | Open → |
| FY20152016-03-31 | $8.0M | +300.4% | Open → |
| FY20142015-03-31 | $2.0M | +46.6% | Open → |
| FY20132014-03-31 | $1.4M | +25.4% | Open → |
| FY20122013-03-31 | $1.1M | −22.8% | Open → |
| FY20112012-03-31 | $1.4M | — | Open → |
Gross profit — Gross profit is revenue minus the direct cost of goods and services sold. Not every company reports it; those that do not are absent from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +32.8%
Gross profit at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elite Pharmaceuticals gross profit |url=https://companiesranked.com/en/company/elite-pharmaceuticals/gross-profit |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elite Pharmaceuticals gross profit. CompaniesRanked. https://companiesranked.com/en/company/elite-pharmaceuticals/gross-profitBibTeX
@misc{companiesranked-en-company-elite-pharmaceuticals-gross-profit-2026,
author = {{CompaniesRanked}},
title = {{Elite Pharmaceuticals gross profit}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elite-pharmaceuticals/gross-profit}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001493152-26-031070 · June 29, 2026
{{cite web |title=Elite Pharmaceuticals gross profit — 10-K (0001493152-26-031070) |url=https://www.sec.gov/Archives/edgar/data/1053369/000149315226031070/form10-k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.